Back
Theravance Biopharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
TBPH
Theravance Biopharma, Inc.
Last Price:
$19.52
Seasonality Move:
2.25%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight selling pressure.
Theravance Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.69 | Sell |
| 20-day SMA: | 19.79 | Sell |
| 50-day SMA: | 19.11 | Buy |
| 200-day SMA: | 14.42 | Buy |
| 8-day EMA: | 18.35 | Buy |
| 20-day EMA: | 13.11 | Buy |
| 50-day EMA: | 7 | Buy |
| 200-day EMA: | 2.05 | Buy |
Theravance Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.27 | Buy |
| Relative Strength Index (14 RSI): | 50.25 | Buy |
| Chaikin Money Flow: | -123021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.32 - 20.32) | Sell |
| Bollinger Bands (100): | (15.01 - 19.69) | Buy |
Theravance Biopharma, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma, Inc. Stock
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 19.53 while TBPH 8-day simple moving average is 19.69, which is a Sell signal.
-
The stock price of TBPH is 19.53 while Theravance Biopharma, Inc. 20-day SMA is 19.79, which makes it a Sell.
-
Theravance Biopharma, Inc. 50-day simple moving average is 19.11 while TBPH share price is 19.53, making it a Buy technically.
-
TBPH stock price is 19.53 and Theravance Biopharma, Inc. 200-day simple moving average is 14.42, creating a Buy signal.
TBPH Technical Analysis vs Fundamental Analysis
Buy
59
Theravance Biopharma, Inc. (TBPH)
is a Buy
Is Theravance Biopharma, Inc. a Buy or a Sell?
-
Theravance Biopharma, Inc. stock is rated a BuyThe current Theravance Biopharma, Inc. [TBPH] share price is $19.53. The Score for TBPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Theravance Biopharma, Inc. Stock Info
Market Cap:
989.6M
Price in USD:
19.53
Share Volume:
395K
Theravance Biopharma, Inc. 52-Week Range
52-Week High:
21.03
52-Week Low:
7.90
Buy
59
Theravance Biopharma, Inc. (TBPH)
is a Buy
Theravance Biopharma, Inc. Share Price Forecast
-
What is the Theravance Biopharma, Inc. stock price today?The Theravance Biopharma, Inc. stock price is 19.53 USD today.
-
Will TBPH stock go up or go down?Theravance Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Theravance Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma, Inc. is not overvalued.
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 19.53 while TBPH 8-day exponential moving average is 18.35, which is a Buy signal.
-
The stock price of TBPH is 19.53 while Theravance Biopharma, Inc. 20-day EMA is 13.11, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day exponential moving average is 7.00 while TBPH share price is 19.53, making it a Buy technically.
-
TBPH stock price is 19.53 and Theravance Biopharma, Inc. 200-day simple moving average is 2.05, creating a Buy signal.
Fundamental Analysis of Theravance Biopharma, Inc.
Is Theravance Biopharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and a decrease next year of $1.62 per share.
Technical Analysis of Theravance Biopharma, Inc.
Should I short Theravance Biopharma, Inc. stock?
-
TBPH Moving Average Covergence Divergence (MACD) indicator is 5.27, suggesting Theravance Biopharma, Inc. is a Buy
-
Theravance Biopharma, Inc. Relative Strength Index (RSI) is 50.25, which suggest Theravance Biopharma, Inc. is overbought
-
The Bollinger Bands (25) for Theravance Biopharma, Inc. is (19.32 - 20.32), which suggest Theravance Biopharma, Inc. is a Buy
-
The Bollinger Bands (100) for Theravance Biopharma, Inc. is (15.01 - 19.69), which suggest Theravance Biopharma, Inc. is a Buy
* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.